Advice Page

< Return to Search Results

Drug Details

Drug Number: 531/09
Drug Name: pemetrexed (Alimta)
Drug Manufacturer: Eli Lilly & Company Ltd
BNF Category: Malignant disease and immunosuppression
Submission type : Resubmission
Date Advice Issued: 08.06.09
Indication: First line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

Drug Advice

pemetrexed (Alimta)

Press Statement

Read the press statement

Link opens in new windowRead the briefing note

Minutes

Read the minutes

Notes

< Return to Search Results







Help on how to improve your search.